MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
基本信息
- 批准号:6825223
- 负责人:
- 金额:$ 34.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:DNA methylationadipocytesbiological signal transductionbone development disordercell differentiationcell lineclinical researchembryonic stem cellfamily geneticsgene expressiongene mutationgene targetinggenetic disordergenetic polymorphismgenetic regulationgenetically modified animalsguanine nucleotide binding proteinhuman subjectlaboratory mousemessenger RNAnucleic acid sequenceosteoblastspluripotent stem cellspolymerase chain reactionsite directed mutagenesis
项目摘要
DESCRIPTION (provided by applicant): Genetic disorders of osteogenesis provide valuable insight into the regulation of bone formation. Progressive osseous heteroplasia (POH) is a rare and disabling genetic disorder in which the body produces bone in skin, fat and skeletal muscle. Gene mutations in POH patients inactivate one of the two copies of the GNAS gene and alter the fate of cells to cause bone formation in inappropriate locations (heterotopic ossification). GNAS encodes the G(s)alpha protein, which couples signaling via cell surface receptors to intracellular second messengers, however the specific effects of these mutations on bone cell differentiation are unknown. Ectopic bone formation in POH patients often arises within subcutaneous fat, suggesting a close, perhaps reciprocal, relationship between bone and fat cell differentiation. In addition to continuing investigations of GNAS inheritance and expression in POH, a primary goal of this proposal is to examine the effects of heterozygous inactivating GNAS mutations on bone (osteoblast) and fat (adipocyte) cell differentiation. We hypothesize that: (1) Heterozygous inactivating mutation of the GNAS gene alters cellular signaling that directs osteoblast and/or adipocyte differentiation, and (2) The complex phenotypic consequences of inactivating GNAS mutations are influenced by maternal/paternal inheritance of GNAS. The following Specific Aims will be conducted: 1. Investigate the parental origin of the GNAS allele that carries GNAS mutations in POH patients. 2. Examine POH genomic DNA for methylation characteristic of imprinting at the GNAS locus. 3. Examine the differential expression of GNAS mRNAs during osteoblast and adipocyte differentiation. 4. Examine the effects of heterozygous GNAS gene inactivation on osteoblast and adipocyte differentiation. 5. Investigate the effects of an inactive GNAS gene on expression of specific GNAS transcripts during osteoblast and adipocyte differentiation. The overall goal of this project is to characterize the role of the GNAS gene in the regulation of bone cell differentiation. The studies described in this proposal will provide the foundation to examine the specific pathways through which GNAS regulates osteogenesis. These investigations will provide important information for developing diagnostic and treatment strategies for a wide range of disorders of bone such as POH and more common conditions.
描述(由申请人提供):成骨的遗传疾病为调节骨形成提供了宝贵的见解。进行性骨性异质(POH)是一种罕见且残疾的遗传疾病,人体在皮肤,脂肪和骨骼肌中产生骨骼。 POH患者的基因突变使GNA基因的两个副本之一失活,并改变了细胞的命运以在不适当的位置引起骨形成(异位骨化)。 GNA编码G(s)α蛋白,该蛋白通过细胞表面受体的信号传导与细胞内第二使者,但是这些突变对骨细胞分化的特定影响尚不清楚。 POH患者的异位骨形成通常发生在皮下脂肪中,表明骨与脂肪细胞分化之间的关系很近,可能是相互的。除了对POH中的GNA遗传和表达的持续研究外,该建议的主要目标是检查杂合灭活GNA突变对骨(成骨细胞)和脂肪(脂肪细胞)细胞分化的影响。我们假设:(1)GNA基因的杂合灭活突变改变了指导成骨细胞和/或脂肪细胞分化的细胞信号传导,以及(2)灭活GNAS突变的复杂表型后果受母体/父亲/父亲的gnas遗传的影响。将进行以下具体目的:1。研究POH患者携带GNA突变的GNA等位基因的父母来源。 2。检查POH基因组DNA,以了解GNA基因座的印迹的甲基化特征。 3。检查成骨细胞和脂肪细胞分化过程中GNAS mRNA的差异表达。 4。检查杂合子GNA基因失活对成骨细胞和脂肪细胞分化的影响。 5。研究非活性GNA基因对成骨细胞和脂肪细胞分化过程中特定GNA转录本的表达的影响。该项目的总体目标是表征GNA基因在调节骨细胞分化中的作用。该提案中描述的研究将为检查GNA调节成骨的特定途径提供基础。这些调查将为开发诊断和治疗策略的重要信息,以针对POH等多种骨骼疾病以及更常见的疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EILEEN M SHORE其他文献
EILEEN M SHORE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EILEEN M SHORE', 18)}}的其他基金
Advances in Mineral Metabolism (AIMM) Annual Meeting
矿物质代谢进展 (AIMM) 年会
- 批准号:
10752804 - 财政年份:2023
- 资助金额:
$ 34.87万 - 项目类别:
Avances in Mineral Metabolism (AIMM) meeting
矿物质代谢进展 (AIMM) 会议
- 批准号:
10614914 - 财政年份:2020
- 资助金额:
$ 34.87万 - 项目类别:
Advances in Mineral Metabolism(AIMM) 2019 annual meeting
矿物质代谢进展(AIMM)2019年会
- 批准号:
9760686 - 财政年份:2019
- 资助金额:
$ 34.87万 - 项目类别:
Advances in Mineral Metabolism (AIMM) 2016 annual meeting
矿物质代谢进展 (AIMM) 2016 年会
- 批准号:
9335546 - 财政年份:2017
- 资助金额:
$ 34.87万 - 项目类别:
Advances in Mineral Metabolism (AIMM) 2015 annual meeting
矿物质代谢进展 (AIMM) 2015 年会
- 批准号:
8911461 - 财政年份:2015
- 资助金额:
$ 34.87万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
7924441 - 财政年份:2009
- 资助金额:
$ 34.87万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
6090796 - 财政年份:2000
- 资助金额:
$ 34.87万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
7118627 - 财政年份:2000
- 资助金额:
$ 34.87万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
7485034 - 财政年份:2000
- 资助金额:
$ 34.87万 - 项目类别:
MOLECULAR GENETICS OF PROGRESSIVE OSSEOUS HETEROPLASIA
进行性骨异质发育的分子遗传学
- 批准号:
7268813 - 财政年份:2000
- 资助金额:
$ 34.87万 - 项目类别:
相似国自然基金
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
- 批准号:82300966
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
CD36/FABP4/CPT1轴介导脂肪酸转运促进白血病干细胞的维持在白血病化疗耐药中的作用及机制研究
- 批准号:82300206
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
放射后早期神经元-星形胶质细胞脂肪酸代谢耦联对正常脑组织免疫微环境的重塑及其机制研究
- 批准号:82373516
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高原低氧上调肝脏ANGPTL4基因的表达导致巨噬细胞M1/M2比例失衡从而促进肝脂肪化的机制研究
- 批准号:82360333
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
AMYLOIDOGENIC INDUCTION OF CELLULAR SENESCENCE IN ALZHEIMER'S DISEASE
阿尔茨海默病中细胞衰老的淀粉样诱导
- 批准号:
10672372 - 财政年份:2020
- 资助金额:
$ 34.87万 - 项目类别:
Understanding Progesterone Receptor action in Obesity for Endometrial Cancer Prevention
了解孕酮受体在肥胖中的作用以预防子宫内膜癌
- 批准号:
10221650 - 财政年份:2019
- 资助金额:
$ 34.87万 - 项目类别:
Early life n-3 fatty acids increase novel Adipogenesis-regulatory cells to condition adipogenesis in a NR2F2 dependent manner
生命早期 n-3 脂肪酸增加新型脂肪生成调节细胞,以 NR2F2 依赖性方式调节脂肪生成
- 批准号:
9807608 - 财政年份:2019
- 资助金额:
$ 34.87万 - 项目类别:
Mitochondrial metabolic regulation of lung epithelium: alveolar generation and regeneration
肺上皮的线粒体代谢调节:肺泡的生成和再生
- 批准号:
10681479 - 财政年份:2019
- 资助金额:
$ 34.87万 - 项目类别:
Understanding Progesterone Receptor action in Obesity for Endometrial Cancer Prevention
了解孕酮受体在肥胖中的作用以预防子宫内膜癌
- 批准号:
10680493 - 财政年份:2019
- 资助金额:
$ 34.87万 - 项目类别: